Home > Cashflow Statement > NEULAND LABORATORIES

NEULAND LABORATORIES
Cash Flow from Operating Activities

    Back to Cashflow Statement
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results

NEULAND LABORATORIES Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Operating Activities ₹347 Cr₹317 Cr₹261 Cr₹237 Cr₹60 Cr

What is the latest Cash Flow from Operating Activities ratio of NEULAND LABORATORIES ?

The latest Cash Flow from Operating Activities ratio of NEULAND LABORATORIES is ₹347 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Operating Activities
Mar2026₹347 Cr
Mar2025₹317 Cr
Mar2024₹261 Cr
Mar2023₹237 Cr
Mar2022₹60 Cr

How is Cash Flow from Operating Activities of NEULAND LABORATORIES Trending?

Years Cash Flow from Operating Activities % Change
Mar2026 ₹347 Cr
9.22
Mar2025 ₹317 Cr
21.53
Mar2024 ₹261 Cr
10.10
Mar2023 ₹237 Cr
292.81
Mar2022 ₹60 Cr -

Compare Cash Flow from Operating Activities of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹26,773.2 Cr 6.2% 2.8% 13.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹452,707.0 Cr 1.4% 6.7% 12% Stock Analytics
DIVIS LABORATORIES ₹303,962.0 Cr 11.1% 23.5% 70% Stock Analytics
TORRENT PHARMACEUTICALS ₹179,494.0 Cr 1% 1.8% 34.3% Stock Analytics
DR REDDYS LABORATORIES ₹115,769.0 Cr 1.1% 11.8% 14.2% Stock Analytics
CIPLA ₹113,912.0 Cr 0.1% 6% -5.8% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

6.2%

2.8%

13.4%

SENSEX

3.3%

13.9%

-1.7%


You may also like the below Video Courses